Skip to content
akaturk Academic measurement

Article detail · 2024 · article

Comparision of Perioperative Fluoropyrimidine, Docetaxel And Oxaliplatin Regimen with Adjuvant Fluoropyrimidine and Oxaliplatine Regimen In Operable Gastric Cancer Patients

Journal Journal of Biotechnology and Strategic Health Research
ISSN2587-1641
YÖKSİS OpenAlex Open access · diamond
Year2024
Citations0OpenAlex
Percentile%32.1
FWCI0.01.00 = world average

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueJournal of Biotechnology and Strategic Health Research
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Aim: As no study has compared perioperative 5-Fluorouracil (5-FU), oxaliplatin, and docetaxel (FLOT) chemotherapy regimens with postoperative adjuvant oral capecitabine and oxaliplatin/5-FU and oxaliplatin (CAPEOX/FOLFOX) chemotherapy regimens, the goal of this study was to compare them in terms of median and overall survival of operable gastric cancers. Methods: This single-center, retrospective study recruited 59 subjects (17 females and 42 males) with at least T2 or more invasive gastric cancers with or without positive lymph node(s). All the patients underwent total or subtotal ((sub) total) gastric resection with D2 lymph node dissection. The Statistical Package for the Social Sciences (IBM SPSS) 26.0 program was used to statistically analyze the research findings. Results: The peri-operative FLOT treatment group with 30 patients displayed significantly more advanced clinical nodal (cN) stage (p

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

0citationsOpenAlex · cited_by_count (cache / database)

Authors

4
  1. ASLI YILDIRIM 1
  2. ZEYNEP ERGENÇ YALOVA ÜNİVERSİTESİ 2
  3. Nihal Kaplan Bozdağ 3
  4. HASAN ERGENÇ 4